NU SKIN ENTERPRISES INC - A (NUS) Fundamental Analysis & Valuation

NYSE:NUS • US67018T1051

Current stock price

7.17 USD
+0.06 (+0.84%)
At close:
7.17 USD
0 (0%)
After Hours:

This NUS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NUS Profitability Analysis

1.1 Basic Checks

  • In the past year NUS was profitable.
  • In the past year NUS had a positive cash flow from operations.
  • Of the past 5 years NUS 4 years were profitable.
  • In the past 5 years NUS always reported a positive cash flow from operatings.
NUS Yearly Net Income VS EBIT VS OCF VS FCFNUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • NUS has a better Return On Assets (11.40%) than 83.78% of its industry peers.
  • Looking at the Return On Equity, with a value of 19.90%, NUS belongs to the top of the industry, outperforming 89.19% of the companies in the same industry.
  • NUS has a better Return On Invested Capital (6.50%) than 62.16% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NUS is significantly below the industry average of 11.32%.
  • The 3 year average ROIC (4.60%) for NUS is below the current ROIC(6.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.4%
ROE 19.9%
ROIC 6.5%
ROA(3y)0.63%
ROA(5y)3.08%
ROE(3y)-0.52%
ROE(5y)5.25%
ROIC(3y)4.6%
ROIC(5y)7.93%
NUS Yearly ROA, ROE, ROICNUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

1.3 Margins

  • The Profit Margin of NUS (10.79%) is better than 86.49% of its industry peers.
  • NUS's Profit Margin has improved in the last couple of years.
  • NUS has a better Operating Margin (6.12%) than 62.16% of its industry peers.
  • In the last couple of years the Operating Margin of NUS has declined.
  • NUS's Gross Margin of 69.45% is in line compared to the rest of the industry. NUS outperforms 56.76% of its industry peers.
  • NUS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.12%
PM (TTM) 10.79%
GM 69.45%
OM growth 3Y-5.09%
OM growth 5Y-9.32%
PM growth 3Y31.83%
PM growth 5Y7.79%
GM growth 3Y-1.04%
GM growth 5Y-1.4%
NUS Yearly Profit, Operating, Gross MarginsNUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NUS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUS is destroying value.
  • NUS has less shares outstanding than it did 1 year ago.
  • NUS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NUS has been reduced compared to a year ago.
NUS Yearly Shares OutstandingNUS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
NUS Yearly Total Debt VS Total AssetsNUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.71 indicates that NUS is not in any danger for bankruptcy at the moment.
  • NUS has a better Altman-Z score (3.71) than 81.08% of its industry peers.
  • NUS has a debt to FCF ratio of 4.87. This is a neutral value as NUS would need 4.87 years to pay back of all of its debts.
  • NUS's Debt to FCF ratio of 4.87 is fine compared to the rest of the industry. NUS outperforms 70.27% of its industry peers.
  • NUS has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • NUS's Debt to Equity ratio of 0.25 is in line compared to the rest of the industry. NUS outperforms 59.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.87
Altman-Z 3.71
ROIC/WACC0.91
WACC7.15%
NUS Yearly LT Debt VS Equity VS FCFNUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.08 indicates that NUS has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.08, NUS is in line with its industry, outperforming 45.95% of the companies in the same industry.
  • A Quick Ratio of 1.40 indicates that NUS should not have too much problems paying its short term obligations.
  • NUS has a Quick ratio (1.40) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.4
NUS Yearly Current Assets VS Current LiabilitesNUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NUS Growth Analysis

3.1 Past

  • NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.76%, which is quite impressive.
  • The earnings per share for NUS have been decreasing by -18.78% on average. This is quite bad
  • Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -14.26% in the last year.
  • The Revenue for NUS have been decreasing by -10.47% on average. This is quite bad
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
Revenue 1Y (TTM)-14.26%
Revenue growth 3Y-12.62%
Revenue growth 5Y-10.47%
Sales Q2Q%-16.89%

3.2 Future

  • The Earnings Per Share is expected to grow by 1.27% on average over the next years.
  • Based on estimates for the next years, NUS will show a small growth in Revenue. The Revenue will grow by 1.05% on average per year.
EPS Next Y-21.71%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NUS Yearly Revenue VS EstimatesNUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
NUS Yearly EPS VS EstimatesNUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

8

4. NUS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.56, which indicates a rather cheap valuation of NUS.
  • 97.30% of the companies in the same industry are more expensive than NUS, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of NUS to the average of the S&P500 Index (25.70), we can say NUS is valued rather cheaply.
  • The Price/Forward Earnings ratio is 7.10, which indicates a rather cheap valuation of NUS.
  • 91.89% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. NUS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.56
Fwd PE 7.1
NUS Price Earnings VS Forward Price EarningsNUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • NUS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NUS is cheaper than 100.00% of the companies in the same industry.
  • 89.19% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.5
EV/EBITDA 2.27
NUS Per share dataNUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The decent profitability rating of NUS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.27%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NUS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.38%, NUS has a reasonable but not impressive dividend return.
  • The stock price of NUS dropped by -32.42% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.68, NUS pays a better dividend. On top of this NUS pays more dividend than 81.08% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, NUS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.38%

5.2 History

  • The dividend of NUS decreases each year by -30.34%.
  • NUS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-30.34%
Div Incr Years0
Div Non Decr Years0
NUS Yearly Dividends per shareNUS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • NUS pays out 7.39% of its income as dividend. This is a sustainable payout ratio.
DP7.39%
EPS Next 2Y1.27%
EPS Next 3YN/A
NUS Yearly Income VS Free CF VS DividendNUS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
NUS Dividend Payout.NUS Dividend Payout, showing the Payout Ratio.NUS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NUS Fundamentals: All Metrics, Ratios and Statistics

NU SKIN ENTERPRISES INC - A

NYSE:NUS (3/13/2026, 8:04:00 PM)

After market: 7.17 0 (0%)

7.17

+0.06 (+0.84%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners77.81%
Inst Owner Change1.2%
Ins Owners2.96%
Ins Owner Change23.34%
Market Cap345.09M
Revenue(TTM)1.49B
Net Income(TTM)160.20M
Analysts45
Price TargetN/A
Short Float %4.26%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield 3.38%
Yearly Dividend0.24
Dividend Growth(5Y)-30.34%
DP7.39%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.96%
Min EPS beat(2)-4.29%
Max EPS beat(2)12.21%
EPS beat(4)3
Avg EPS beat(4)38.88%
Min EPS beat(4)-4.29%
Max EPS beat(4)73.83%
EPS beat(8)6
Avg EPS beat(8)39.66%
EPS beat(12)9
Avg EPS beat(12)28.85%
EPS beat(16)12
Avg EPS beat(16)23.55%
Revenue beat(2)0
Avg Revenue beat(2)-3.91%
Min Revenue beat(2)-4.19%
Max Revenue beat(2)-3.63%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-4.19%
Max Revenue beat(4)2.51%
Revenue beat(8)4
Avg Revenue beat(8)-1.07%
Revenue beat(12)5
Avg Revenue beat(12)-1.25%
Revenue beat(16)6
Avg Revenue beat(16)-1.69%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-44.44%
EPS NQ rev (3m)-44.44%
EPS NY rev (1m)-29.58%
EPS NY rev (3m)-29.58%
Revenue NQ rev (1m)-7.59%
Revenue NQ rev (3m)-7.59%
Revenue NY rev (1m)-6.67%
Revenue NY rev (3m)-6.67%
Valuation
Industry RankSector Rank
PE 5.56
Fwd PE 7.1
P/S 0.23
P/FCF 7.5
P/OCF 4.3
P/B 0.43
P/tB 0.51
EV/EBITDA 2.27
EPS(TTM)1.29
EY17.99%
EPS(NY)1.01
Fwd EY14.09%
FCF(TTM)0.96
FCFY13.33%
OCF(TTM)1.67
OCFY23.27%
SpS30.86
BVpS16.73
TBVpS14.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number22.04
Profitability
Industry RankSector Rank
ROA 11.4%
ROE 19.9%
ROCE 7.96%
ROIC 6.5%
ROICexc 8.23%
ROICexgc 9.57%
OM 6.12%
PM (TTM) 10.79%
GM 69.45%
FCFM 3.1%
ROA(3y)0.63%
ROA(5y)3.08%
ROE(3y)-0.52%
ROE(5y)5.25%
ROIC(3y)4.6%
ROIC(5y)7.93%
ROICexc(3y)5.71%
ROICexc(5y)10.2%
ROICexgc(3y)7.03%
ROICexgc(5y)13.41%
ROCE(3y)5.63%
ROCE(5y)9.71%
ROICexgc growth 3Y-12.47%
ROICexgc growth 5Y-21.24%
ROICexc growth 3Y-9.16%
ROICexc growth 5Y-17.8%
OM growth 3Y-5.09%
OM growth 5Y-9.32%
PM growth 3Y31.83%
PM growth 5Y7.79%
GM growth 3Y-1.04%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.87
Debt/EBITDA 1.43
Cap/Depr 65.59%
Cap/Sales 2.31%
Interest Coverage 5.44
Cash Conversion 56.09%
Profit Quality 28.72%
Current Ratio 2.08
Quick Ratio 1.4
Altman-Z 3.71
F-Score7
WACC7.15%
ROIC/WACC0.91
Cap/Depr(3y)69.21%
Cap/Depr(5y)75.81%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
EPS Next Y-21.71%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.26%
Revenue growth 3Y-12.62%
Revenue growth 5Y-10.47%
Sales Q2Q%-16.89%
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.98%
EBIT growth 3Y-17.06%
EBIT growth 5Y-18.81%
EBIT Next Year130.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.42%
FCF growth 3Y-2.08%
FCF growth 5Y-31.95%
OCF growth 1Y-28.15%
OCF growth 3Y-9.44%
OCF growth 5Y-26.69%

NU SKIN ENTERPRISES INC - A / NUS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?

ChartMill assigns a fundamental rating of 6 / 10 to NUS.


What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?

ChartMill assigns a valuation rating of 8 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.


How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?

NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for NUS stock?

The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 5.56 and the Price/Book (PB) ratio is 0.43.


Can you provide the dividend sustainability for NUS stock?

The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 7.39%.